NHS SUPPLY CHAIN ACTING AS AGENT FOR SUPPLY CHAIN COORDINATION LTD has floated a tender for Liquid Based Cytology Systems and High-Risk Human Papillomavirus Testing Systems for Cervical Cancer. The project location is United Kingdom and the tender is closing on 23 May 2019. The tender notice number is APR292186, while the TOT Ref Number is 32425582. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : United Kingdom

Summary : Liquid Based Cytology Systems and High-Risk Human Papillomavirus Testing Systems for Cervical Cancer

Deadline : 23 May 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 32425582

Document Ref. No. : APR292186

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NHS SUPPLY CHAIN ACTING AS AGENT FOR SUPPLY CHAIN COORDINATION LTD
NHS Supply Chain acting as agent for Supply Chain Coordination Ltd
528867
WA4 6HL
Stockton Heath
UK61
UK
Contact person : Katy Barker
Telephone : +44 1925692028
E-mail : pathology@supplychain.nhs.uk
NUTS : UKD61
Internet address(es)
Main address : www.supplychain.nhs.uk

United Kingdom
Email :pathology@supplychain.nhs.uk
URL :www.supplychain.nhs.uk

Tender Details

NHS Supply Chain seeks to establish a comprehensive, non-exclusive, Framework Agreement for the supply to the NHS Supply Chain customer base via the E-Direct/Direct Route of liquid based cytology systems and high-risk human papillomavirus testing systems for cervical cancer screening.



Title: Liquid Based Cytology Systems and High-Risk Human Papillomavirus Testing Systems for Cervical Cancer

Published by: NHS Supply Chain acting as agent for Supply Chain Coordination Ltd

Publication Date: 18/04/2019

Deadline Date: 23/05/2019

Deadline Time: 15:00

Notice Type: Contract Notice

Has Documents: No

Has ESPD: No

Abstract: Rental and capital pricing including equipment, products, reagents and services required for cervical cancer screening — Liquid Based Cytology (LBC).The Framework Agreement will have an initial term of 24 months with an option to extend incrementally 12 months at a time, up to a total period of 48 months.Precise quantities of likely purchases are unknown. Value excluding VAT: between 290 000 GBP and 574 000 GBP by the end of Year 2 the total value of the anticipated contracts (with a maximum award of 7 years) awarded under the resulting Framework Agreement are estimated to be in the region 1 020 000 and 2 040 000.





Estimated total value: Value excluding VAT: 204 000 000.00GBP

Documents

 Tender Notice